Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,287 | 16 | 74.8% |
| Travel and Lodging | $10,314 | 21 | 14.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,745 | 4 | 8.1% |
| Food and Beverage | $1,938 | 30 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $68,592 | 51 | $0 (2023) |
| GENZYME CORPORATION | $2,185 | 10 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $300.37 | 4 | $0 (2019) |
| CardioFocus, Inc. | $92.77 | 1 | $0 (2018) |
| RedDress USA, Inc. | $42.14 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $40.13 | 2 | $0 (2023) |
| Novo Nordisk Inc | $18.50 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.08 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.22 | 2 | RedDress USA, Inc. ($42.14) |
| 2023 | $17,545 | 14 | Biogen, Inc. ($17,505) |
| 2021 | $8,090 | 8 | Biogen, Inc. ($8,072) |
| 2020 | $10,627 | 6 | Biogen, Inc. ($10,627) |
| 2019 | $32,363 | 26 | Biogen, Inc. ($32,293) |
| 2018 | $382.00 | 5 | Novartis Pharmaceuticals Corporation ($157.34) |
| 2017 | $2,221 | 10 | GENZYME CORPORATION ($2,148) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: GENETIC DISEASE | ||||||
| 01/03/2024 | RedDress USA, Inc. | — | Food and Beverage | In-kind items and services | $42.14 | General |
| 08/24/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,969.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $626.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $392.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $240.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $220.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $154.00 | General |
| 08/24/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $84.30 | General |
| 08/24/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 08/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Gastroenterology | ||||||
| 07/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Gastroenterology | ||||||
| 03/31/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,904.00 | General |
| 03/31/2023 | Biogen, Inc. | — | Travel and Lodging | In-kind items and services | $968.00 | General |
| 03/31/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $98.80 | General |
| 03/08/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,839.00 | General |
| 11/30/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,149.00 | General |
| 11/17/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,298.00 | General |
| 11/17/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.77 | General |
| 10/20/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,149.00 | General |
| 05/18/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,149.00 | General |
| 03/19/2021 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,149.00 | General |
| 02/17/2021 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,149.00 | General |
| 02/03/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Obesity | ||||||
| 08/07/2020 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 2,419 | $754,950 | $304,412 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0277 | Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | Office | 2023 | 20 | 1,926 | $385,200 | $260,520 | 67.6% |
| 99183 | Management of oxygen chamber therapy | Office | 2023 | 20 | 493 | $369,750 | $43,892 | 11.9% |
About Dr. John Deluca, M.D
Dr. John Deluca, M.D is a Undersea and Hyperbaric Medicine healthcare provider based in North Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407050024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Deluca, M.D has received a total of $71,284 in payments from pharmaceutical and medical device companies, with $55.22 received in 2024. These payments were reported across 71 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($53,287).
As a Medicare-enrolled provider, Deluca has provided services to 40 Medicare beneficiaries, totaling 2,419 services with total Medicare billing of $304,412. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Undersea and Hyperbaric Medicine
- Other Specialties Internal Medicine
- Location North Palm Beach, FL
- Active Since 06/14/2007
- Last Updated 12/12/2022
- Taxonomy Code 2083P0011X
- Entity Type Individual
- NPI Number 1407050024
Products in Payments
- DISEASE STATE (Drug) $1,819
- GILENYA (Drug) $217.70
- LEMTRADA (Drug) $129.66
- MS DISEASE STATE (Drug) $123.33
- TYSABRI (Biological) $94.89
- PIPELINE-MS (Drug) $87.22
- MAYZENT (Drug) $82.67
- XIFAXAN (Drug) $40.13
- AUBAGIO (Drug) $25.39
- Saxenda (Drug) $18.50
- VPRIV (Biological) $13.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.